Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Adel Mohamed Kamal El-Etriby & Sameh Rakha. (2020) Efficacy and safety of amlodipine/valsartan/hydrochlorothiazide single pill combination in Egyptian patients with hypertension uncontrolled on any dual therapy: an observational study. Current Medical Research and Opinion 36:4, pages 537-544.
Read now
Read now
Yong Huo, Ye Gu, Genshan Ma, Jincheng Guo, Longgen Xiong, Zhurong Luo, Jianhong Xie, Weimin Li, Jianrong Zhao, Xiaowei Yan, Wei Liu, Yawei Xu, Xiaomei Bao, Luosha Zhao, Ming Yang, Bei Wang & The China STATUS III Study Group. (2019) China STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive patients: a one-year registry (China STATUS III). Current Medical Research and Opinion 35:8, pages 1441-1449.
Read now
Read now
Jorge Sison, Rosa María Ríos Vega, Hu Dayi, Giovanni Bader & Patrick Brunel. (2018) Efficacy and effectiveness of valsartan/amlodipine and valsartan/amlodipine/hydrochlorothiazide in hypertension: randomized controlled versus observational studies. Current Medical Research and Opinion 34:3, pages 501-515.
Read now
Read now
Samir Helmy Assaad-Khalil, Robert Najem, Jorge Sison, Asad Riaz Kitchlew, Belong Cho, Kwo-Chang Ueng, Shelley DiTommaso & Abhijit Shete. (2015) Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups. Vascular Health and Risk Management 11, pages 71-78.
Read now
Read now
Articles from other publishers (11)
Jamshed Dalal, J. P. Sawhney, P. B. Jayagopal, P. K. Hazra, Mohammed Yunus Khan, Kumar Gaurav, Colette Pinto, Amey Mane, Sachin Rao & Madhur Jain. (2022) A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine. International Journal of Hypertension 2022, pages 1-9.
Crossref
Crossref
Mohammed Yunus Khan, Sucheta Pandit, Saumitra Ray, Jagdish Chander Mohan, B. C. Srinivas, Santosh Ramakrishnan, Amey Mane, Suyog Mehta & Snehal Shah. (2020) Effectiveness of Amlodipine on Blood Pressure Control in Hypertensive Patients in India: A Real-World, Retrospective Study from Electronic Medical Records. Drugs - Real World Outcomes 7:4, pages 281-293.
Crossref
Crossref
Jaejin An, Catherine G. Derington, Tiffany Luong, Kari L. Olson, Jordan B. King, Adam P. Bress & Cynthia A. Jackevicius. (2020) Fixed-Dose Combination Medications for Treating Hypertension: A Review of Effectiveness, Safety, and Challenges. Current Hypertension Reports 22:11.
Crossref
Crossref
Abdul Salam, Mark D. Huffman, Raju Kanukula, Esam Hari Prasad, Abhishek Sharma, David J. Heller, Rajesh Vedanthan, Anubha Agarwal, Anthony Rodgers, Marc G. Jaffe, Thomas Frieden & Sandeep P. Kishore. (2020) Two‐drug fixed‐dose combinations of blood pressure‐lowering drugs as WHO essential medicines: An overview of efficacy, safety, and cost. The Journal of Clinical Hypertension 22:10, pages 1769-1779.
Crossref
Crossref
Sung-Ji Park & Si Jae Rhee. (2020) Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Essential Hypertension (RESOLVE): A Large, Observational, Retrospective, Cohort Study. Advances in Therapy 37:8, pages 3500-3514.
Crossref
Crossref
Massimo Volpe, Giovanna Gallo & Giuliano Tocci. (2020) New approach to blood pressure control: Triple combination pill. Trends in Cardiovascular Medicine 30:2, pages 72-77.
Crossref
Crossref
Youngkeun Ahn, Yongcheol Kim, Kiyuk Chang, Weon Kim, Moo-Yong Rhee, Kwang Soo Cha, Min Su Hyon, Chi Young Shim, Sung Yun Lee, Doo Il Kim, Sang Wook Kim, Sang-Wook Lim, Kyoo-Rok Han, Sang-Ho Jo, Nae-Hee Lee, Jun Kwan & Taehoon Ahn. (2018) A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy. Medicine 97:37, pages e12329.
Crossref
Crossref
R Düsing, B Waeber, M Destro, C Santos Maia & P Brunel. (2017) Triple-combination therapy in the treatment of hypertension: a review of the evidence. Journal of Human Hypertension 31:8, pages 501-510.
Crossref
Crossref
Muhammad Ali Sheraz, Syed Furqan Ahsan, Marium Fatima Khan, Sofia Ahmed & Iqbal Ahmad. (2016) Formulations of Amlodipine: A Review. Journal of Pharmaceutics 2016, pages 1-11.
Crossref
Crossref
Samir H. Assaad-Khalil & Nashwa Nashaat. (2016) Real-life Effectiveness and Safety of Amlodipine/Valsartan Single-pill Combination in Patients with Hypertension in Egypt: Results from the EXCITE Study. Drugs - Real World Outcomes 3:3, pages 307-315.
Crossref
Crossref
Ana Rodríguez de Ledesma. (2015) Treatment of Hypertension in New Frontiers. EMJ Cardiology, pages 44-52.
Crossref
Crossref